| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
-0.25 |
7e-07 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
7e-07 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.26 |
8e-07 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
| mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
| mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |